Pathways of neurodegeneration and experimental models of basal ganglia disorders: Downstream effects of mitochondrial inhibition

被引:22
作者
Di Filippo, Massimiliario
Picconi, Barbara
Costa, Cinzia
Bagetta, Vincenza
Tantucci, Michela
Parnetti, Lucilla
Calabresi, Paolo
机构
[1] Univ Perugia, Osped Silvestrini, Neurol Clin, I-06156 Perugia, Italy
[2] IRCCS, Fdn Santa Lucia, Rome, Italy
关键词
basal ganglia; Parkinson's disease; Huntington's disease; mitochondria;
D O I
10.1016/j.ejphar.2006.06.024
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The basal ganglia circuit plays a key role in the regulation of voluntary movernents as well as in behavioural control and cognitive functions. The main pathogenic role of mitochondrial dysfunctions is now accepted in the neurodegenerative process and the mitochondria have been successfully used as subcellular targets to obtain relevant experimental models of basal ganglia neurodegenerative disorders. Mitochondrial toxins act through an inhibition of the respiratory chain complexes. These toxins, by uncoupling cellular respiration, shift the cell into a state of oxidative stress and trigger several bidirectional links with the excitotoxic process. Moreover, the in vitro inhibition of the respiratory chain complexes alters the electrophysiological properties of the neurons. The downstream effects triggered by mitochondrial complexes inhibition provide a model integrating genetic and environmental pathogenic factors to explain the selective neuronal vulnerability. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 75 条
[1]  
ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63
[2]   Oxidative stress in neurodegeneration: cause or consequence? [J].
Andersen, JK .
NATURE MEDICINE, 2004, 10 (07) :S18-S25
[3]   Mitochondria take center stage in aging and neurodegeneration [J].
Beal, MF .
ANNALS OF NEUROLOGY, 2005, 58 (04) :495-505
[4]   Experimental therapeutics in transgenic mouse models of Huntington's disease [J].
Beal, MF ;
Ferrante, RJ .
NATURE REVIEWS NEUROSCIENCE, 2004, 5 (05) :373-384
[5]   Experimental models of Parkinson's disease [J].
Beal, MF .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) :325-332
[6]  
BEAL MF, 1993, J NEUROSCI, V13, P4181
[7]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[8]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[9]   Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons [J].
Bonsi, P ;
Calabresi, P ;
De Persis, C ;
Papa, M ;
Centonze, D ;
Bernardi, G ;
Pisani, A .
EXPERIMENTAL NEUROLOGY, 2004, 185 (01) :169-181
[10]   Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates [J].
Brouillet, E ;
Hantraye, P .
CURRENT OPINION IN NEUROLOGY, 1995, 8 (06) :469-473